APPENDIX IX
969
TABLE IX-1 (
continued
.)
Present Reference
Interval
Component
(Examples)
Present
Unit
Conversion
Factor
SI
Reference
Interval
SI Unit
Symbol
Significant
Digits
Suggested
Minimum
Increment
Bile acids, total (S) (as
Trace-3.3
|Ug/mL
2.547
Trace-8.4
mmol/L
X.X
0.2 mmol/L
chenodeoxycholic acid)
cholic acid
Trace-1.0
jlig/mL
2.448
Trace-2.4
jUntol/L
X.X
0.2 jumol/L
chenodeoxycholic acid
Trace-1.3
jUg/mL
2.547
Trace-3.4
mmol/L
X.X
0.2 mmol/L
deoxycholic acid
Trace-1.0
jU
g/mL
2.547
Trace-2.6
mmol/L
X.X
0.2 JUmol/L
lithocholic acid
Trace
/4g/mL
2.656
Trace
jUmol/L
X.X
0.2 jUmol/L
Bile acids (Df) (after cholecystokinin
stimulation)
total as chenodeoxycholic acid
14.0-58.0
mg/mL
2.547
35.0-148.0
mmol/L
XX.X
0.2 mmol/L
cholic acid
2.4-33.0
mg/mL
2.448
6.8-81.0
mmol/L
XX.X
0.2 mmol/L
chenodeoxycholic acid
4.0-24.0
mg/mL
2.547
10.0-61.4
mmol/L
XX.X
0.2 mmol/L
deoxycholic/acid
0.8-6.9
mg/mL
2.547
2.0-18.0
mmol/L
XX.X
0.2 mmol/L
lithocholic acid
0.3-0.8
mg/mL
2.656
0.8-2.0
mmol/L
XX.X
0.2 mmol/L
Bilirubin, total (S)
0
.
1
-
1 .0
mg/dL
17.10
2-18
jUmol/L
XX
2 mmol/L
Bilirubin, conjugated (S)
0-0.2
mg/dL
17.10
0-4
mmol/L
XX
2 jUmol/L
Bromide (S)—toxic
as bromide ion
>120
mg/dL
0.1252
>15
mmol/L
XX
1 mmol/L
as sodium bromide
>150
mg/dL
0.09719
>15
mmol/L
XX
1 mmol/L
>15
mEq/L
1 .0 0
>15
mmol/L
XX
1 mmol/L
Cadmium (S)
<3
№/dL
0.08897
<0.3
mmol/L
X.X
0.1 mmol/L
Calcitonin (S)
<100
pg/mL
1 .0 0
<100
ng/L
XXX
10 ng/L
Calcium (S)
male
8.8-10.3
mg/dL
0.2495
2.20-2.58
mmol/L
X.XX
0.02 mmol/L
female <50 y
8.8-10.0
mg/dL
0.2495
2.20-2.50
mmol/L
x.xx
0.02 mmol/L
female >50 y
8.8-10.2
mg/dL
0.2495
2.20-2.56
mmol/L
X.XX
0.02 mmol/L
4.4-5.1
mEq/L
0.5000
2.20-2.56
mmol/L
x.xx
0.02 mmol/L
Calcium ion (S)
2.00-2.30
mEq/L
0.5000
1.00-1.15
mmol/L
x.xx
0.01 mmol/L
4.00-4.60
mg/dL
0.2495
1.00-1.15
mmol/L
x.xx
0.01 mmol/L
Calcium (U), normal diet
<250
mg/24h
0.02495
<6.2
mmol/d
x.x
0.1 mmol/d
Carbamazepine (P)—therapeutic
4.0-10.0
mg/L
4.233
17-42
JUntol/L
xx
1 mmol/L
Carbon dioxide content (B, P, S)
22-28
mEq/L
1.00
22-28
mmol/L
XX
1 mmol/L
(bicarbonate + C02)
Carbon monoxide (B)
<15
%
0.01
<0.15
1
0.ХХ
0.01
(proportion of Hb that is СОНЬ)
Beta-carotenes (S)
50-250
/Ug/dL
0.01863
0.9^1.6
jumol/L
x.x
0.1 /nmol/L
Catecholamines, total (U)
<120
mg/24h
5.911
<675
nmol/d
xxo
10 mg/d
(as norepinephrine)
Ceruloplasmin (S)
20-35
mg/dL
10.0
200-350
mg/L
xxo
10 mg/L
Chlordiazepoxide (P)—
therapeutic
0.5-5.0
mg/L
3.336
2-17
jUntol/L
XX
1 jttmol/L
toxic
>10.0
mg/L
3.336
>33
jUmol/L
XX
1 mmol/L
Chloride (S)
95-105
mEq/L
1 .0 0
95-105
mmol/L
XXX
1 mmol/L
Chlorimipramine (P) (includes
50-400
ng/mL
3.176
150-1270
nmol/L
XXO
10 nmol/L
desmethyl metabolite)
Chlorpromazine (P)
50-300
ng/mL
3.136
150-950
nmol/L
xxo
10 nmol/L
Chlorpropamide (P)—therapeutic
75-250
mg/L
3.613
270-900
mmol/L
xxo
10mmol/L
Cholestanol (P) (as a fraction of
1-3
%
0.01
0.01-0.03
1
o.xx
0.01
total cholesterol)
Cholesterol (P)
<29 years "I
3U-39 years 1
40-49 years
\
<200
mg/dL
0.02586
<5.20
mmol/L
x.xx
0.05 mmol/L
>50 years
J
Cholesterol esters (P) (as a fraction
60-75
%
0.01
0.60-0.75
1
o.xx
0.01
of total cholesterol)
Cholinesterase (S)
620-1370
U/L
0.01667
10.3-22.8
jUkat/L
XX.X
0.1 mkat/L
Chorionic gonadotrophin (P)
0 if not
mIU/mL
1 .0 0
0 if not
IU/L
XX
1 IU/L
(beta-hCG)
Citrate (B) (as citric acid)
pregnant
1.2-3.0
mg/dL
52.05
pregnant
60-160
jUmol/L
XXX
5 mmol/L
Complement, C3 (S)
70-160
mg/dL
0.01
0.7-1.6
g/L
x.x
0.1 g/L
Complement, C4 (S)
20-40
mg/dL
0.01
0.2-0.4
g/L
x.x
0.1 g/L
Copper (S)
70-140
mg/dL
0.1574
11.0-22.0
mmol/L
XX.X
0.2 mmol/L
Copper (U)
<40
mg/24h
0.01574
<0.6
jLimol/d
x.x
0.2 mmol/d
